Cytonus Therapeutics, Inc.
Regulation Crowdfunding offering on Wefunder
$0
of $1M goal
0.0% funded
About the offering
Axiom Biosciences is a clinical-stage biotechnology company that develops precision regenerative stem cell therapies for neonatal brain injury and stroke in San Diego, California.
FAQ
How much has Cytonus Therapeutics, Inc. raised?
Cytonus Therapeutics, Inc. has raised $0 of a $1M goal.
Where is Cytonus Therapeutics, Inc.'s campaign live?
The offering is live on Wefunder, an SEC-registered Reg CF intermediary.
What are the terms of Cytonus Therapeutics, Inc.'s raise?
Preferred Stock, $80M cap, $12.04/share.
When does Cytonus Therapeutics, Inc.'s offering close?
The stated close date is Apr 30, 2027.